We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+9.41%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$1.27B
AUM Growth
+$102M
Cap. Flow
+$13.4M
Cap. Flow %
1.05%
Top 10 Hldgs %
34.43%
Holding
2,813
New
122
Increased
1,063
Reduced
999
Closed
97

Sector Composition

Rank Sector Weight
1 Technology 15.34%
2 Financials 8.08%
3 Healthcare 7.07%
4 Consumer Staples 6.48%
5 Consumer Discretionary 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOBL icon
2101
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$10.1K ﹤0.01%
200
ERII icon
2102
Energy Recovery
ERII
$433M
$10.1K ﹤0.01%
+641
New +$10.2K
SABR icon
2103
Sabre
SABR
$743M
$10.1K ﹤0.01%
4,172
+2,241
+116% +$7.52K
HTH icon
2104
Hilltop Holdings
HTH
$2.28B
$10.1K ﹤0.01%
322
RKT icon
2105
Rocket Companies
RKT
$39.6B
$10K ﹤0.01%
690
-657
-49% -$8.15K
GME icon
2106
GameStop
GME
$9.94B
$9.99K ﹤0.01%
798
+32
+4% +$464
LBTYA icon
2107
Liberty Global Class A
LBTYA
$3.49B
$9.95K ﹤0.01%
588
DCO icon
2108
Ducommun
DCO
$2.68B
$9.9K ﹤0.01%
193
HOV icon
2109
Hovnanian Enterprises
HOV
$800M
$9.89K ﹤0.01%
63
ADAP
2110
DELISTED
Adaptimmune Therapeutics
ADAP
$9.88K ﹤0.01%
+6,253
New +$7.55K
EZPW icon
2111
Ezcorp Inc
EZPW
$1.85B
$9.88K ﹤0.01%
872
-14
-2% -$138
EDIT icon
2112
Editas Medicine
EDIT
$402M
$9.85K ﹤0.01%
1,327
FLG
2113
Flagstar Bank National Association
FLG
$5.83B
$9.85K ﹤0.01%
1,019
-2,129
-68% -$39.4K
LOVE icon
2114
LoveSac
LOVE
$248M
$9.83K ﹤0.01%
+435
New +$10.1K
NVEE
2115
DELISTED
NV5 Global
NVEE
$9.8K ﹤0.01%
400
-196
-33% -$5.09K
FULC icon
2116
Fulcrum Therapeutics
FULC
$248M
$9.8K ﹤0.01%
+1,038
New +$9.27K
GPRO icon
2117
GoPro
GPRO
$125M
$9.78K ﹤0.01%
4,386
-3,016
-41% -$8.05K
NTB icon
2118
Bank of N.T. Butterfield & Son
NTB
$2.37B
$9.76K ﹤0.01%
305
+129
+73% +$3.92K
SNBR
2119
DELISTED
Sleep Number
SNBR
$9.7K ﹤0.01%
605
+527
+676% +$6.83K
MDU icon
2120
MDU Resources
MDU
$4.31B
$9.65K ﹤0.01%
691
-1,930
-74% -$22.3K
RLI icon
2121
RLI Corp
RLI
$5.97B
$9.65K ﹤0.01%
130
HAE icon
2122
Haemonetics
HAE
$3.75B
$9.64K ﹤0.01%
113
-10
-8% -$785
ROIV icon
2123
Roivant Sciences
ROIV
$24.3B
$9.61K ﹤0.01%
912
TAP icon
2124
Molson Coors Class B
TAP
$7.97B
$9.61K ﹤0.01%
143
-20
-12% -$1.27K
RYAN icon
2125
Ryan Specialty Holdings
RYAN
$5.96B
$9.55K ﹤0.01%
172

Similar funds

Quadrant Capital Group's Q1 2024 Portfolio in Review

As of Q1 2024, Quadrant Capital Group held 2,813 positions worth $1.27B, up 8.8% from $1.16B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Quadrant Capital Group's Q1 2024 filing shows 122 new, 1,063 increased, 999 reduced and 97 closed positions. Its largest new stake was GRIID Infrastructure Inc. Common Stock: 1,465,728 shares worth $1.93M. The largest sale was iShares Global Infrastructure ETF, an estimated $3.78M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Quadrant Capital Group's largest Q1 2024 buy was GRIID Infrastructure Inc. Common Stock: 1,465,728 shares worth $1.93M.
  • Quadrant Capital Group added most to JPMorgan Ultra-Short Income ETF in Q1 2024, an estimated $8.28M increase.
  • Quadrant Capital Group's biggest Q1 2024 reduction was iShares Global Infrastructure ETF, cutting an estimated $3.78M.
  • Quadrant Capital Group fully exited INmune Bio in Q1 2024, selling an estimated $676K.
  • Quadrant Capital Group's ten largest holdings make up 34% of its $1.27B portfolio in Q1 2024.
  • Quadrant Capital Group opened 122 new positions and closed 97 in Q1 2024.
  • Quadrant Capital Group's portfolio value rose 8.8% quarter-over-quarter to $1.27B.

Based on Quadrant Capital Group's 13F filing for Q1 2024, filed 15 May 2024.